share_log

424B2: Prospectus

SEC announcement ·  Apr 19 17:29
Summary by Moomoo AI
Bank of America has announced the pricing of its Contingent Income Auto-Callable Yield Notes, linked to the common stock of CVS Health Corporation, with a due date of April 22, 2027. The Notes, priced on April 17, 2024, will be issued on April 22, 2024, with an approximate term of three years, unless called prior to maturity. Payments on the Notes are contingent on the performance of CVS Health Corporation's stock, with quarterly contingent coupons payable if the stock's value meets specified conditions. The Notes are callable quarterly beginning October 17, 2024, and at maturity, investors are exposed to downside risk if CVS's stock declines by more than 30% from its Starting Value. The Notes are not FDIC insured, not bank guaranteed, and may lose...Show More
Bank of America has announced the pricing of its Contingent Income Auto-Callable Yield Notes, linked to the common stock of CVS Health Corporation, with a due date of April 22, 2027. The Notes, priced on April 17, 2024, will be issued on April 22, 2024, with an approximate term of three years, unless called prior to maturity. Payments on the Notes are contingent on the performance of CVS Health Corporation's stock, with quarterly contingent coupons payable if the stock's value meets specified conditions. The Notes are callable quarterly beginning October 17, 2024, and at maturity, investors are exposed to downside risk if CVS's stock declines by more than 30% from its Starting Value. The Notes are not FDIC insured, not bank guaranteed, and may lose value. They will not be listed on any securities exchange. The initial estimated value of the Notes is $963.90 per $1,000 in principal, which is less than the public offering price. The total underwriting discount and proceeds before expenses to BofA Finance are also detailed. The Notes are subject to the credit risk of BofA Finance LLC and Bank of America Corporation. The CUSIP number is 09711BLS3.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more